Search

Your search keyword '"Marija, Vavlukis"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Marija, Vavlukis" Remove constraint Author: "Marija, Vavlukis" Topic internal medicine Remove constraint Topic: internal medicine
46 results on '"Marija, Vavlukis"'

Search Results

1. Comparison of 24 h ECG Holter Monitoring with Real-time Long-term ECG Monitoring System using ECGalert Software and Savvy Single-Lead Patch

2. Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry

Catalog

Books, media, physical & digital resources

3. Sex-Related Differences in Heart Failure After ST-Segment Elevation Myocardial Infarction

4. Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

5. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

6. Heart Rate Variability of 30-minute ECG Measurements and Correlation to Glucose Levels

7. Abstract 13648: Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease

8. Added Value of Modified Anderson–Wilkins Acuteness Score in Prognostication of Patients with Acute Myocardial Infarction

9. Novel Inflammatory Biomarkers as Additional Value to Traditional Risk-factors in Cardiovascular Risk Stratification

10. Sex Differences in Modifiable Risk Factors and Severity of Coronary Artery Disease

11. Myocardial Infarction in Systemic Lupus Erythematosus - the Sex-Specific Risk Profile

12. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'

13. Myocardial Perfusion Abnormalities in Young and Premenopausal Women with Systemic Lupus Erythematosus, Detected with 99MTC MIBI Myocardial Perfusion Scintigraphy – Prevalence and Correlation with Proatherogenic Factors

14. Adding ezetimibe to statin therapy: latest evidence and clinical implications

15. 'DE NOVO' HEART FAILURE: A MECHANISM UNDERSCORING SEX DIFFERENCES IN OUTCOMES AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION

16. Secondary Thromboprophylaxis in Hereditary Thrombophilia

17. Is there a place for rosuvastatin in the Lp(a) management?

18. Correlating Glucose Regulation with Lipid Profile

19. P3844Percutaneous coronary intervention in the age of frailty

20. SEX DIFFERENCES IN HEART FAILURE FOLLOWING ACUTE CORONARY SYNDROMES

21. STATINS AND SEVERITY OF CLINICAL MANIFESTATIONS AMONG WOMEN AND MEN WITH INCIDENT CORONARY HEART DISEASE

22. The Impact of Glyco-Metabolic Status in Patients Treated for Acute Coronary Syndrome

23. P580Sex difference in the impact of delay to reperfusion on coronary blood flow and outcomes in ST-segment elevation myocardial infarction

24. Newly Diagnosed Diabetes and Stress Glycaemia and Its’ Association with Acute Coronary Syndrome

25. 2018 ESC Guidelines for the diagnosis and management of syncope

26. Effects of High Intensity Statin Therapy in the Treatment of Diabetic Dyslipidemia in Patients with Coronary Artery Disease

27. Influence of ABCB1 C3435T Genotype on Clinical Cardiovascular Outcomes in Coronary Artery Disease Patients on Clopidogrel Treatment

28. Antiphospholipid Syndrome - A Case Report of Pulmonary Thromboembolism, Followed with Acute Myocardial Infarction in Patient with Systemic Sclerosis

29. Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on Outcomes

30. Cardiovascular Disease

31. Functional outcome and quality of life after coronary artery bypass surgery in patients with severe heart failure and hibernated myocardium

32. Mo-P4:253 Relationship between extend of myocardial viability and post-revascularization improvement of left ventricular ejection fraction

33. ESTIMATION OF METABOLIC SYNDROME' COMPONENTS IN TYPE 2 DIABETIC POPULATION WITH CORONARY ARTERY DISEASE – A COMPARISON OF TWO CRITERIA

34. 6.20hs-CRP values in patients with normal myocardial perfusion

35. 8.1Influence of hibernated myocardium on left ventricular remodelling in patients with severe ischaemic heart failure and coronary artery bypass surgery

36. 1.18Combined low level treadmill-dipyridamol versus dipyridamol stress protocol in patients undergoing SPECT MPI

37. 6.29Diagnostic value of transient ischaemic dilation (TID) and increased lung uptake as markers of severe and extensive myocardial ischaemia

38. Is there a relationship between myocardial perfusion scintigraphy and carotid ultrasound findings in predictive model for coronary artery bypass patients?

39. Prognosis and risk stratification of diabetic patients after coronary stenting: Impact of silent ischemia on cardiovascular events

40. M.521 Implication of body mass index on long-term prognosis in patients after coronary artery bypass surgery

41. 7.58 Myocardial viability: nitrate enhanced gated SPECT MIBI Tc99m an adequate alternation for Tl201 rest-redistribution protocol

42. 1.25 Dipyridamole myoscintigraphy in patients with left bundle branch block

43. 1.38 Significance of ST-segment changes detected by ambulatory electrocardiographic monitoring and exercise treadmill stress testing in female patients who underwent myocardial perfusion scintigraphy

44. 16.10 Evaluation of diagnostic and prognostic markers of myocardial perfusion scintigraphy and exercise treadmill stress test in patients with multivessel coronary artery disease

45. Myocardial perfusion scintigraphic findings in patients with ischaemic cardyomiopathy versus those with preserved left ventricular function

46. Bisoprolol reduces episodes of ventricular tachycardia and sudden cardiac death in subjects with chronic heart failure